Global Bloodstream Infection Testing Market 2020-2024

SKU ID :TNV-16881481 | Published Date: 12-Nov-2020 | No. of pages: 120
• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Market characteristics o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2019 o Market outlook: Forecast for 2019 - 2024 • Five Forces Analysis o Five forces summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Technology o Market segments o Comparison by Technology o Conventional testing - Market size and forecast 2019-2024 o Non-conventional testing - Market size and forecast 2019-2024 o Market opportunity by Technology • Customer landscape o Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o Asia - Market size and forecast 2019-2024 o ROW - Market size and forecast 2019-2024 o Key leading countries o Market opportunity by geography o Market drivers o Market challenges o Market trends • Vendor Landscape o Vendor landscape o Landscape disruption o Competitive Scenario • Vendor Analysis o Vendors covered o Market positioning of vendors o Abbott Laboratories o Accelerate Diagnostics Inc. o bioMérieux SA o Bruker Corp. o Danaher Corp. o F. Hoffmann-La Roche Ltd. o Grifols SA o Siemens Healthineers AG o Thermo Fisher Scientific Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibit • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2019 - 2024 ($ million) • 13: Global market: Year-over-year growth 2019 - 2024 (%) • 14: Five forces analysis 2019 & 2024 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2019 • 21: Technology - Market share 2019-2024 (%) • 22: Comparison by Technology • 23: Conventional testing - Market size and forecast 2019-2024 ($ million) • 24: Conventional testing - Year-over-year growth 2019-2024 (%) • 25: Non-conventional testing - Market size and forecast 2019-2024 ($ million) • 26: Non-conventional testing - Year-over-year growth 2019-2024 (%) • 27: Market opportunity by Technology • 28: Customer landscape • 29: Market share by geography 2019-2024 (%) • 30: Geographic comparison • 31: North America - Market size and forecast 2019-2024 ($ million) • 32: North America - Year-over-year growth 2019-2024 (%) • 33: Europe - Market size and forecast 2019-2024 ($ million) • 34: Europe - Year-over-year growth 2019-2024 (%) • 35: Asia - Market size and forecast 2019-2024 ($ million) • 36: Asia - Year-over-year growth 2019-2024 (%) • 37: ROW - Market size and forecast 2019-2024 ($ million) • 38: ROW - Year-over-year growth 2019-2024 (%) • 39: Key leading countries • 40: Market opportunity by geography ($ million) • 41: Impact of drivers and challenges • 42: Vendor landscape • 43: Landscape disruption • 44: Industry risks • 45: Vendors covered • 46: Market positioning of vendors • 47: Abbott Laboratories - Overview • 48: Abbott Laboratories - Business segments • 49: Abbott Laboratories - Key offerings • 50: Abbott Laboratories - Key customers • 51: Abbott Laboratories - Segment focus • 52: Accelerate Diagnostics Inc. - Overview • 53: Accelerate Diagnostics Inc. - Business segments • 54: Accelerate Diagnostics Inc. - Key offerings • 55: Accelerate Diagnostics Inc. - Key customers • 56: Accelerate Diagnostics Inc. - Segment focus • 57: Becton, Dickinson and Co. - Overview • 58: Becton, Dickinson and Co. - Business segments • 59: Becton, Dickinson and Co. - Key offerings • 60: Becton, Dickinson and Co. - Key customers • 61: Becton, Dickinson and Co. - Segment focus • 62: bioMérieux SA - Overview • 63: bioMérieux SA - Business segments • 64: bioMérieux SA - Key offerings • 65: bioMérieux SA - Key customers • 66: bioMérieux SA - Segment focus • 67: Bruker Corp. - Overview • 68: Bruker Corp. - Business segments • 69: Bruker Corp. - Key offerings • 70: Bruker Corp. - Key customers • 71: Bruker Corp. - Segment focus • 72: Danaher Corp. - Overview • 73: Danaher Corp. - Business segments • 74: Danaher Corp. - Key offerings • 75: Danaher Corp. - Key customers • 76: Danaher Corp. - Segment focus • 77: F. Hoffmann-La Roche Ltd. - Overview • 78: F. Hoffmann-La Roche Ltd. - Business segments • 79: F. Hoffmann-La Roche Ltd. - Key offerings • 80: F. Hoffmann-La Roche Ltd. - Key customers • 81: F. Hoffmann-La Roche Ltd. - Segment focus • 82: Grifols SA - Overview • 83: Grifols SA - Business segments • 84: Grifols SA - Key offerings • 85: Grifols SA - Key customers • 86: Grifols SA - Segment focus • 87: Siemens Healthineers AG - Overview • 88: Siemens Healthineers AG - Business segments • 89: Siemens Healthineers AG - Key offerings • 90: Siemens Healthineers AG - Key customers • 91: Siemens Healthineers AG - Segment focus • 92: Thermo Fisher Scientific Inc. - Overview • 93: Thermo Fisher Scientific Inc. - Business segments • 94: Thermo Fisher Scientific Inc. - Key offerings • 95: Thermo Fisher Scientific Inc. - Key customers • 96: Thermo Fisher Scientific Inc. - Segment focus • 97: Currency conversion rates for US$ • 98: Research Methodology • 99: Validation techniques employed for market sizing • 100: Information sources • 101: List of abbreviations
Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMérieux SA, Bruker Corp., Danaher Corp., F. Hoffmann-La Roche Ltd., Grifols SA, Siemens Healthineers AG, Thermo Fisher Scientific Inc.
  • PRICE
  • $2500
    $5000
    Buy Now

Our Clients